Who is sponsoring NCT05307029?

NCT05307029 is sponsored by University of Roma La Sapienza.

What drugs are being tested in NCT05307029?

Interventions in NCT05307029: rehabilitation with fixed full-arch prosthesis.

What condition does NCT05307029 study?

NCT05307029 studies Edentulous Patients.

Is NCT05307029 still recruiting?

NCT05307029 is currently completed. Last updated 1 April 2022.

Last reviewed 2022-04-01 · How we verify

NCT05307029

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Immediate and Flapless Full-arch Rehabilitation of Edentulous Jaws

Completed Last updated 1 April 2022

What this trial tests

trial testing rehabilitation with fixed full-arch prosthesis in Edentulous Patients in 28 participants. Completed in 26 February 2019.

Timeline

20 February 2009

Primary endpoint
10 February 2014

26 February 2019

Quick facts

Lead sponsor	University of Roma La Sapienza
Status	Completed
Study type	OBSERVATIONAL
Enrollment	28
Start date	20 February 2009
Primary completion	10 February 2014
Estimated completion	26 February 2019

Drugs / interventions tested

rehabilitation with fixed full-arch prosthesis

Conditions studied

Edentulous Patients — all drugs for Edentulous Patients →

Sponsor

University of Roma La Sapienza

Who can join

Eligibility, any sex, with Edentulous Patients. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study involved 28 edentulous patients (20 female/8 males; average age of 67.75± 8.627 years) rehabilitated with 33 prostheses (17 all-on-4/16 all-on-6) supported by 164 implants.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Immediate flapless full-arch rehabilitation of edentulous jaws on 4 or 6 implants according to the prosthetic-driven planning and guided implant surgery: A retrospective study on clinical and radiographic outcomes up to 10 years of follow-up.
La Monaca G, Pranno N, Annibali S, Di Carlo S, et al · · 2022 · cited 25× · PMID 36197040 · DOI 10.1111/cid.13134

Verify or expand the search:

Other University of Roma La Sapienza trials

Trials by the same sponsor.

NCT07485023 — Oral Versus Intravenous Iron for Anemia Diagnosed After 34 Weeks of Gestation · NA · not yet recruiting
NCT07305519 — The Combined Effect of Magnesium, Palmitoylethanolamide, High-Molecular-weight Hyaluronic Acid, Vitamin B6, and Vitamin · NA · not yet recruiting
NCT07520968 — ABX Versus CHX in NSPT: a RCT · NA · active not recruiting
NCT07109596 — Integration of Clinical, Biological and Psycho-social Variables for a Gender-sensitive Frailty Prediction · recruiting
NCT07490574 — Trial of Underwater Versus Gas-Insufflation Colorectal Endoscopic Submucosal DisseEtion · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05307029 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Roma La Sapienza
Last refreshed: 1 April 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05307029.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing